603392 万泰生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额197,7951,537,8234,132,5931,681,948468,206
投资活动产生之现金流量净额(841,978)(2,053,737)(3,513,902)(1,014,103)(295,398)
筹资活动产生之现金流量净额(619,649)(893,260)3,126,89652,785379,791
汇率变动对现金及现金等价物的影响(3,470)7,61926,262(8,746)(9,009)
现金及现金等价物净增加/(减少)(1,267,301)(1,401,554)3,771,849711,884543,590
期初现金及现金等价物余额3,783,6425,185,1961,413,347701,463157,873
期末现金及现金等价物余额2,516,3413,783,6425,185,1961,413,347701,463